Back to Treatments

Treatment

Pegylated Interferon-alpha

1
Conditions
30
Trials
1,500
Participants
30%
Average Safety

Condition Evidence

Acute hepatitis E

30 trials · 1,500 participants

60% effectiveness · 30% safety
Pegylated Interferon-alpha | DFDA